Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- IMvigor130
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
Cancer Bladder Cancer Urothelial Carcinoma
Study results
IMvigor130_LPS_ 2020May_English
(PDF, 0.6 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Bosnia
(PDF, 0.9 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Brazil
(PDF, 0.8 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Chile
(PDF, 0.2 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Chinese_Hong Kong
(PDF, 1.3 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Czech_Republic
(PDF, 0.7 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_English_Hong Kong
(PDF, 0.9 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Estonia
(PDF, 1.1 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Finland
(PDF, 0.4 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_French_Belgium
(PDF, 1.0 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Georgia
(PDF, 0.6 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Greece
(PDF, 0.9 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Israel
(PDF, 0.9 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Italy
(PDF, 0.5 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Japan
(PDF, 1.0 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Korea
(PDF, 0.8 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Mexico
(PDF, 0.4 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Netherlands
(PDF, 0.2 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Netherlands_Belgium
(PDF, 0.8 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Poland
(PDF, 1.2 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Portugal
(PDF, 1.0 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Romania
(PDF, 0.9 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Russia
(PDF, 1.0 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Russian_Ukraine
(PDF, 1.0 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Slovenia
(PDF, 1.5 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Spain
(PDF, 0.8 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Taiwan
(PDF, 1.2 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Thailand
(PDF, 1.0 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_Ukraine
(PDF, 0.7 MB)
LPS_WO30070_IMvigor130_final results_23Feb2022_United kingdom
(PDF, 0.9 MB)
LPS_WO30070_IMvigor130_final results_16March2020_Singapore
(PDF, 1.8 MB)
LPS_WO30070_IMvigor130_final results_November2019_Spain
(PDF, 0.8 MB)
LPS_WO30070_IMvigor130_final results_November2019_Turkey
(PDF, 0.6 MB)
LPS_WO30070_IMvigor130_final results_November2019_China
(PDF, 0.7 MB)
LPS_WO30070_IMvigor130_final results_November2019_Serbia
(PDF, 1.2 MB)
LPS WO30070 IMvigor130 Final Results May 2023 English
(PDF, 1.3 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com